{"id":"NCT00335725","sponsor":"IBSA Institut Biochimique SA","briefTitle":"Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.","officialTitle":"Multicentric Prospective, Randomised, Controlled Clinical Study on Clinical Efficacy and Tolerability of Urinary FSH (Fostimon速 , IBSA) Versus r-FSH (Gonal-F速, Serono) in ICSI.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-03","primaryCompletion":"2005-12","completion":"2005-12","firstPosted":"2006-06-12","resultsPosted":"2015-03-27","lastUpdate":"2015-03-27"},"enrollment":151,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Infertility"],"interventions":[{"type":"DRUG","name":"Follicle Stimulating Hormone","otherNames":["highly purified human derived FSH; Fostimon"]},{"type":"DRUG","name":"Follicle Stimulating Hormone","otherNames":["rec FSH; Gonal F"]}],"arms":[{"label":"Fostimon","type":"EXPERIMENTAL"},{"label":"Gonal-F","type":"ACTIVE_COMPARATOR"}],"summary":"Purpose of the study is the comparative evaluation of the clinical efficacy and of the general tolerability of two different subcutaneous FSH preparations (Fostimon速 IBSA Vs Gonal-F速 Serono) when administered in patients undergoing ICSI","primaryOutcome":{"measure":"Total Number of Oocytes Retrieved","timeFrame":"10 days after stimulation start","effectByArm":[{"arm":"Fostimon","deltaMin":10.9,"sd":4.9},{"arm":"Gonal-f","deltaMin":12,"sd":5.6}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":7,"countries":["France","Hungary"]},"refs":{"pmids":["13611018","5481991","720642","6778212","622235","8019294","8006130","7989500","10469682","2492145","474642","6419189","3275976","1868645","6768596"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":73},"commonTop":["Ovarian cyst","spontaneous abortion","tiredness"]}}